Guido Tricot, MD, PhD
Director, Stem Cell Transplant and Myeloma Program
University of Utah School of Medicine
Salt Lake City, Utah, United States
Guido Tricot, MD, PhD, is the director of Huntsman Cancer Institute's Myeloma Program. He has been researching and treating multiple myeloma for over twenty years. Tricot is also a professor in the Department of Medicine at the University of Utah School of Medicine.
His team's treatment strategies are based on tandem autologous transplantation, a treatment approach that has increased the median survival rate of patients to ten years or more, compared to 2.5 to 3 years with conventional chemotherapy. The long-term outcome data of Dr. Tricot's work have been published extensively.
He has received several research grants from the National Cancer Institute and has been principal investigator on many myeloma clinical trials.
Dr. Tricot regularly gives presentations on multiple myeloma all over the United States and the world. His research has appeared in numerous publications, including New England Journal of Medicine, the Lancet, the Journal of Clinical Oncology, Blood, Cancer Research, Clinical Cancer Research, the British Journal of Haematology, Seminars in Hematology, and Hematology/Oncology Clinics of North America. He is also a peer reviewer for many medical journals.
He received his medical and doctoral degree at the University of Leuven in Belgium. Before joining Huntsman Cancer Institute, he was Director of Clinical Research at the University of Arkansas Myeloma Institute for Research and Therapy, the largest myeloma program in the world.
Dr. Tricot has also served as Director of Bone Marrow and Stem Cell Transplantation at the Greenebaum Cancer Center at the University of Maryland and at Indiana University.
Video Interview with Guido Tricot, recorded at the ICDO Summit 2009:
Audio Interview with Guido Tricot, recorded at the ICDO Summit 2009: